 Artist: Mysterium: mp3 download Genre(s): Other Metal Discography:  Soulwards Year: 2003 Tracks: 8  The Glowering Facades Of Nights Year: 2000 Tracks: 8 Featuring Peter Domma (guitars/vocals), Norman Al-Rubai (guitars), Timo Wohlfahrt (bass), Andreas Landvoigt (keyboards) and André Holstein (drums), German mediaeval metallic element band Mysterium debuted with 2000's Glowering Facades of the Night -- its folky tendencies enhanced by client vocalist/flautist Sabine Tiefensee. Choosing to focal point on the heavier aspects of their songwriting, the radical returned significantly more metallic and jactitation bang-up end alloy monikers (Sagron, Gwydion, Orpheus, etc.) for 2003's Soulwards record album. |
Saturday 23 August 2008
Download Mysterium mp3
Wednesday 13 August 2008
Download Hank Mobley
 Artist: Hank Mobley: mp3 download Genre(s): Jazz Discography:  Dippin' Year: 2006 Tracks: 1  Reach Out Year: 2005 Tracks: 6  Soul Station Year: 1999 Tracks: 6  Vol 20 - Jimmy Raney Year: 1979 Tracks: 21  Poppin Year: Tracks: 5 One of the Blue Note label's authoritative difficult bop artists, tenor saxophonist Hank Mobley remains somewhat underappreciated for his square, swinging dash. Any characterisation of Mobley always begins with critic Leonard Feather's asseveration that he was the "middleweight champion of the tenor sax," meaning that his tonus wasn't as fast-growing and wooden-headed as John Coltrane or Sonny Rollins, merely neither was it as soft and cool as Stan Getz or Lester Young. Instead, Mobley's middle, "round" (as he described it) sound was controlled and even, apt over to subtlety genial of than intense displays of emotion. Even if he lacked the electric, mercurial qualities of the era's cracking tenor innovators, Mobley remained systematically strong passim most of his recording calling. His solo lines were full of intricate rhythmical patterns that were delivered with spot-on preciseness, and he was no slouch harmonically either. As a charter member of Horace Silver's Jazz Messengers, Mobley helped introduce the difficult bop social movement: malarky that balanced sophistication and soul, complexity and earthy dangle, and whose at large anatomical LC244% enjoyed a positivist reassessment; with it came a raw appreciation for Mobley's extremely developed talents as a composer and soloist, kinda of a centering on his shortcomings. |
Wednesday 6 August 2008
How Much Does Atrial Fibrillation Cost The German Health Care System?
� In light of the ageing population, the escalating price impact of diseases common in the elderly on a country's health upkeep budget is of increasing importance.
A country-specific rating of the costs associated with this condition is important for both clinicians and wellness care planners.
A recent study, "The costs of care in atrial fibrillation and the effect of treatment modalities in Germany," published in Value in Health, estimated a disease-related cost of over �660 million to the German healthcare system, with 44% of the costs attributed to hospital in-patient care and 56% for outpatient care. Substantially higher costs were incurred by patients requiring handling to govern their heart rhythm in comparison to those world Health Organization required treatment to decrease their eye rate or other therapies. The study was co-authored by Doreen McBride, Anna Mattenklotz, Stefan Willich and Bernd Br�ggenj�rgen of the Institute for Social Medicine, Epidemiology and Health Economics at the Charit� University Medical Center.
Atrial fibrillation is ane of the most common heart arrhythmias, affecting 6% of the great unwashed over 65 years of age. Because of the associated increased risk of stroke, the treatment of atrial fibrillation includes controlling the increased heart rate and temporary rhythm, as well as preventing virgule through the use of blood thinners.
Says Dr. McBride, "The real-life cost evaluation of this sketch demonstrates pronounced economic burden due to atrial fibrillation. Efforts to reduce the high cost of atrial fibrillation should focus on optimization of current treatment modalities in stroke bar and spunk rhythm ascendency, thereby reducing the need for infirmary admissions."
Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health guardianship leaders to make decisions that are solidly evidence-based. The journal is promulgated bi-monthly and has a regular readership of o'er 3,000 clinicians, decision-makers, and researchers worldwide.
ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fair, and efficiently.
Value in Health Volume 12 Issue 2 -March/April 2009
ABSTRACT
http://www.ispor.org
More info
A country-specific rating of the costs associated with this condition is important for both clinicians and wellness care planners.
A recent study, "The costs of care in atrial fibrillation and the effect of treatment modalities in Germany," published in Value in Health, estimated a disease-related cost of over �660 million to the German healthcare system, with 44% of the costs attributed to hospital in-patient care and 56% for outpatient care. Substantially higher costs were incurred by patients requiring handling to govern their heart rhythm in comparison to those world Health Organization required treatment to decrease their eye rate or other therapies. The study was co-authored by Doreen McBride, Anna Mattenklotz, Stefan Willich and Bernd Br�ggenj�rgen of the Institute for Social Medicine, Epidemiology and Health Economics at the Charit� University Medical Center.
Atrial fibrillation is ane of the most common heart arrhythmias, affecting 6% of the great unwashed over 65 years of age. Because of the associated increased risk of stroke, the treatment of atrial fibrillation includes controlling the increased heart rate and temporary rhythm, as well as preventing virgule through the use of blood thinners.
Says Dr. McBride, "The real-life cost evaluation of this sketch demonstrates pronounced economic burden due to atrial fibrillation. Efforts to reduce the high cost of atrial fibrillation should focus on optimization of current treatment modalities in stroke bar and spunk rhythm ascendency, thereby reducing the need for infirmary admissions."
Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health guardianship leaders to make decisions that are solidly evidence-based. The journal is promulgated bi-monthly and has a regular readership of o'er 3,000 clinicians, decision-makers, and researchers worldwide.
ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fair, and efficiently.
Value in Health Volume 12 Issue 2 -March/April 2009
ABSTRACT
http://www.ispor.org
More info
- Fourth International Consultation On Incontinence (ICI) - Vesicovaginal Fistula In The Developing World Committee Highlights
- Protecting The Hearts Of Patients With Muscular Dystrophy Using New Approach
- Preregistration Trainee Pharmacist Training Programme 2008/2009 - National Pharmacy Association, UK
- Obama Should ‘End War’ On Sex Education, Sharing Of Accurate Sex Information, Opinion Piece Says
- CMS Allocating $49M To High-Risk Health Insurance Pools In 31 States
Subscribe to:
Posts (Atom)